These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 35730068)

  • 61. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.
    Song H; Liu D; Wang L; Liu K; Chen C; Wang L; Ren Y; Ju B; Zhong F; Jiang X; Wang G; Chen ZS; Zou C
    Mol Cancer; 2022 Feb; 21(1):43. PubMed ID: 35144642
    [TBL] [Abstract][Full Text] [Related]  

  • 62. VIRMA contributes to non-small cell lung cancer progression via N
    Xu Y; Chen Y; Yao Y; Xie H; Lu G; Du C; Cheng J; Zhou J
    Cancer Lett; 2021 Dec; 522():142-154. PubMed ID: 34520821
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N
    Li Y; He L; Wang Y; Tan Y; Zhang F
    Bioengineered; 2022 May; 13(5):11923-11932. PubMed ID: 35546050
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
    Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The m6A writer KIAA1429 regulates photoaging progression via MFAP4-dependent collagen synthesis.
    Liu Y; Li J; Wang C; Li J; Luo K; Tao K; Tian Y; Song X; Zhai Z; Tao Y; You J; Wu L; Li W; Jiao Y; Yang R; Zhang M
    BMC Biol; 2024 Sep; 22(1):192. PubMed ID: 39256796
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
    Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
    Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
    Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
    Tian L; Wang Y; Tian J; Song W; Li L; Che G
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
    [TBL] [Abstract][Full Text] [Related]  

  • 72. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
    Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
    Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner.
    Hao W; Chen Z; Tang J; Yang R; Gao WQ; Xu H
    J Transl Med; 2023 Nov; 21(1):861. PubMed ID: 38017546
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Wei K; Gao Y; Wang B; Qu YX
    Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
    [TBL] [Abstract][Full Text] [Related]  

  • 76. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.
    Liang J; Cai H; Hou C; Song F; Jiang Y; Wang Z; Qiu D; Zhu Y; Wang F; Yu D; Hou J
    Clin Sci (Lond); 2023 Sep; 137(17):1373-1389. PubMed ID: 37615536
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 78. METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression.
    Peng W; Fu J; Zhou L; Duan H
    Cancer Med; 2024 Jul; 13(13):e7420. PubMed ID: 38967523
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Arumugam P; George R; Jayaseelan VP
    Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
    [TBL] [Abstract][Full Text] [Related]  

  • 80. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.